98%
921
2 minutes
20
Background: Preclinical and postmortem studies have implicated the metabotropic glutamate receptor 5 (mGluR5) in the pathophysiology of major depressive disorder (MDD). The goal of the present study was to determine the role of mGluR5 in a large group of individuals with MDD compared to healthy controls (HC) with [F]FPEB and positron emission tomography (PET). Furthermore, we sought to determine the role glutamate plays on mGluR5 availability in MDD.
Methods: Sixty-five participants (30 MDD and 35 HC) completed [F]FPEB PET to estimate the primary outcome measure - mGluR5 volume of distribution (), and the secondary outcome measure - mGluR5 distribution volume ratio (). A subgroup of 39 participants (16 MDD and 23 HC) completed proton magnetic resonance spectroscopy (H MRS) to estimate anterior cingulate (ACC) glutamate, glutamine, and Glx (glutamate + glutamine) levels relative to creatine (Cr).
Results: No significant between-group differences were observed in mGluR5 . Compared to HC, individuals with MDD had higher ACC glutamate, glutamine, and Glx levels. Importantly, the ACC mGluR5 negatively correlated with glutamate/Cr and Glx/Cr levels.
Conclusions: In this novel examination, we show an inverse relationship between mGluR5 availability and glutamate levels. These data highlight the need to further investigate the role of glutamatergic system in depression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630181 | PMC |
http://dx.doi.org/10.1016/j.bpsc.2017.03.019 | DOI Listing |
Nucl Med Biol
August 2025
Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
Background: Glutamine is an important metabolic substrate in many aggressive tumors, with comparable importance to glucose metabolism. Utilizing human breast cancer mouse xenograft models, we studied the kinetics of the PET imaging agent, L-5-[C]-glutamine ([C]glutamine or [C]GLN) a biochemical authentic substrate for glutamine metabolism, to further characterize the metabolism of glutamine and downstream labeled metabolites. Studies were performed with and without inhibition of the enzyme, glutaminase (GLS), the first step in glutamine catabolism that generates glutamate, and key target for therapy directed to glutamine-metabolizing cancers.
View Article and Find Full Text PDFMagn Reson Med
September 2025
National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
Purpose: To achieve spectrally resolved in vivo detection of glutamate, glutamine, and glutathione at 3 T.
Methods: Difference editing of N-acetylaspartate CH protons (NAA-CH) combined with a new echo-time (TE) optimization approach is introduced. Difference editing was used to detect NAA-CH independently of NAA-CH, thereby eliminating systematic errors arising from constrained fitting of the entire NAA molecule.
Aquac Nutr
August 2025
Guangdong Provincial Key Laboratories of Marine Biotechnology, Shantou University, Shantou 515063, China.
In mammals, cholesterol accumulation in tissues often results in health damage, such as oxidative stress. In contrast, the adverse effects of cholesterol accumulation on the physiological health of fish remain largely unexplored. The present study investigated the impacts of cholesterol accumulation on oxidative stress and the potential mechanisms involved in Nile tilapia ().
View Article and Find Full Text PDFIndian J Endocrinol Metab
August 2025
Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India.
Metabolomics is a type of laboratory science used to understand the cellular and metabolic defects in any disease process. It comprehensively identifies endogenous and exogenous low-molecular-weight (<1 kDa) molecules or metabolites in a high-throughput manner. Mass spectrometry-based methods are used for metabolomics which can be targeted and non-targeted.
View Article and Find Full Text PDFNan Fang Yi Ke Da Xue Xue Bao
August 2025
Department of Nursing, Shenzhen Hospital, Southern Medical University, Shenzhen 518101, China.
Objectives: To investigate the therapeutic effect of acupuncture in a rat model of insomnia and its regulatory effect on the glutamic acid (Glu)/γ-aminobutyric acid (GABA)-glutamine (Gln) metabolic loop.
Methods: Forty male SD rats were randomly assigned to control group, model group, group and group (=10). In the latter 3 groups, rat models of insomnia were established by intraperitoneal injections of p-chlorophenylalanine and verified using a sodium pentobarbital-induced sleep test.